Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

ÃéÀå ¿ÜºÐºñ¿¡ ¹ÌÄ¡´Â Gabexate MegilateÀÇ ¿µÇâ Effect of Gabexate Hesitate on Exocrine Pancreatic Secretion in Rats

´ëÇѼÒÈ­±âÇÐȸÁö 1998³â 32±Ç 3È£ p.376 ~ 382
¼Ò¼Ó »ó¼¼Á¤º¸
ÃÖ¼º±Ô/Sung Kyu Choi ±èÇö¼ö/Á¶Ãµ¿µ/À¯Á¾¼±/±è¼¼Á¾/À±Á¾¸¸/Hyun Soo Kim/Cheon Yeong Cho/Jong Sun Rew/Sei Jong Kim/Chong Mann Yoon

Abstract

¿ä¾à
¸ñÀû : °­·ÂÇÑ ´Ü¹éºÐÇØÈ¿¼Ò ¾ïÁ¦Á¦ÀÎ gabexate mesilate°¡ ±âÀú »óÅÂ¿Í cholecystokinin
ÀÚ±Ø »óÅ¿¡¼­ ÃéÀå ¿ÜºÐºñ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» ÆľÇÇÏ°íÀÚ º» ¿¬±¸¸¦ ½ÃÇàÇÏ¿´´Ù.
´ë»ó ¹× ¹æ¹ý : ¹é¼­¸¦ 12½Ã°£ ±Ý½Ä ÈÄ ¸¶ÃëÇÏ¿¡ °³º¹ÇÏ¿© ´ãÃé°üÀ» PE-10À¸·Î ºÐ¸®ÈÄ
³»°æÁ¤¸ÆÀ» ÅëÇÏ¿© »ý¸®½Ä¿°¼ö (1.56 mL/hr), gabexate mesilate (30 mg/kg) ¹× CCK-8
(3.9 pmol/hr)¸¦ Åõ¿©ÇÑ ÈÄ ÃéÀå¾×À» äÃëÇÏ¿© ÃéÀå¾× ºÐºñ·®, Áßź»ê¿°·® ¹× ´Ü¹é·®À» ÃøÁ¤
ÇÏ¿´´Ù.
°á°ú : ÃéÀå¾× ºÐºñ·®Àº ±âÀú±º¿¡¼­ 20.1¡¾1.1 ¥ìL/30 min, gabexate mesilate Åõ¿©±º¿¡¼­
17.1¡¾1.6 ¥ìL/30 minÀ¸·Î ±âÀú±º°ú ºñ±³½Ã À¯ÀÇÇÑ Â÷ÀÌ°¡ ¾ø¾ú´Ù. CCK-8 Åõ¿©±º¿¡¼­´Â
58.9¡¾3.9 ¥ìL/30 min, CCK-8 ÀÚ±Ø ÈÄ gabexate mesilate Åõ¿©±º 56.2¡¾4.0 ¥ìL/30 min,
gabexate mesilate Åõ¿© ÈÄ CCK-8 Àڱرº¿¡¼­´Â 54.3¡¾3.8 ¥ìL/30 min·Î¼­ ¼¼ ±º°£¿¡ À¯ÀÇ
ÇÑ Â÷ÀÌ°¡ ¾ø¾ú´Ù. ÃéÀå¾× Áß Áßź»ê¿°·®Àº ±âÀú±º¿¡¼­ 30.1¡¾1.3 rmol /30 min, gabexate
mesilate Åõ¿©±º 29.6¡¾1.6 ¥ìmol/30 minÀ¸·Î Â÷ÀÌ°¡ ¾ø¾úÀ¸¸ç, CCK-8 Åõ¿©±º¿¡¼­´Â 193.1
¡¾4.3 ¥ìmol/30 min, CCK-8 ÀÚ±Ø ÈÄ gabexate mesilate Åõ¿©±º 185.¡¾6.7 ¥ìmo1/30 min,
gabexate mesilate Åõ¿© ÈÄ CCK-8 Àڱرº 183.2¡¾5.6 ¥ìmo1/30 min·Î¼­ Áßź»ê¿°·® ¶ÇÇÑ
¼¼ ±º°£ÀÇ À¯ÀÇÇÑ Â÷ÀÌ´Â ¾ø¾ú´Ù. ´Ü¹é·®Àº ±âÀú±º¿¡¼­ 39.8¡¾1.2 ¥ìg/30 minÀ̾úÀ¸³ª
gabexate mesilate Åõ¿©±º¿¡¼­´Â 30.1 ¡¾1.3 ¥ìg/30 minÀ¸·Î À¯ÀÇÇÑ °¨¼Ò°¡ ÀÖ¾úÀ¸¸ç, CCK
Åõ¿©±º¿¡¼­´Â 396.0¡¾6.2 ¥ìg/30 min, CCK-8 ÀÚ±Ø ÈÄ gabexate mesilate Åõ¿©±º 295.9¡¾5.9
¥ìg/30 min, gabexate mesilate Åõ¿© ÈÄ CCK-8 Àڱرº 310.5¡¾7.4 ¥ìg/30 min·Î¼­ ÈÄÀÚ ¾ç
±º°£¿¡¼­´Â À¯ÀÇÇÑ Â÷ÀÌ´Â ¾ø¾úÀ¸³ª, CCK-8 Åõ¿©±º°ú ºñ±³½Ã À¯ÀÇÇÑ °¨¼Ò°¡ ÀÖ¾ú´Ù.
°á·Ð : Gabexate mesilate°¡ ¹é¼­ÀÇ ÃéÀå ¿ÜºÐºñ´É¿¡ ¹ÌÄ¡´Â ¿µÇâÀ¸·Î´Â ÃéÀå¾× ºÐºñ·®°ú
Áßź»ê¿°·®¿¡´Â °ü·ÃÀÌ ¾ø°í ±âÀú »óÅ ¹× CCK ÀÚ±Ø »óÅ¿¡¼­ ´Ü¹é·®À» °¨¼Ò½ÃÅ°´Â °ÍÀ»
È®ÀÎÇÒ ¼ö ÀÖ¾ú´Ù.
#ÃÊ·Ï#
Background/Aims : Gabexate mesilate, a serine protease inhibitor, is a synthetic
compound which is not antigenic and diffuses easily We have investigated the effect of
gabexate mesilate on exocrine pancreatic secretion in rat at basal and
cholecytokinin-stimulated state.
Methods : After anesthetized male Sprague-Dwaley rats were incised in the midline of
abdomen, PE-10 tube was inserted into the pancreatic duct. The secretion was collected
after the ligation of the bile duct between pancreas and liver The volume, of pancreatic
secretion and the amount of bicarbonate and protein in pancreatic secretion were
measured in basal and CCK-8 (3.9 ¥ìmol/hr) stimulated state with and without the
administration of gabexate mesilate (30 mg/kg).
Results : The volume was 20.1¡¾1.1 ¥ìL/30 min in basal state and 58.9¡¾3.9 ¥ìL/3O
min in CCK-8 stimulated state. The amount of bicarbonate in basal and CCK-8
stimulated state was 30.1¡¾1.3 ¥ìmol/ 30 min and 193.1¡¾4.3 ¥ìmo1/30 min, respectively.
After infusion of gabexate, the volume and the amount of bicarbonate were not changed
significantly. The amount of protein was 39.8¡¾1.2 ¥ìg/30 min in basal state and 396.0¡¾
6.2 ¥ìg/30 min in CCK-8 stimulated state. After the infusion of gabexate mesilate, the
amount of the protein in basal and CCK-8 stimulated state was significantly decreased
to 30.1¡¾1.3 ¥ìg/30 min and 295.9¡¾5.9 ¥ìg/30min, respectively (p<0.05).
Conclusions : With the infusion of gabexate mesilate in both basal and CCK
stimulated state of rat, only the protein in pancreatic exocrine secretions was
significantly decreased.

Å°¿öµå

ÃéÀå ¿ÜºÐºñ; Gabexate mesilate; Cholecystokinin; Exocrine pancreatic secretion; Gabexate mesilate; Cholecystokinin;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

MEDLINE
KCI
KoreaMed
KAMS